The DOI matches its Crossref record; the references it cites are not checked yet.
Increased peri‐ductal collagen micro‐organization may contribute to raised mammographic density
Open accessAbstract
BACKGROUND: High mammographic density is a therapeutically modifiable risk factor for breast cancer. Although mammographic density is correlated with the relative abundance of collagen-rich fibroglandular tissue, the causative mechanisms, associated structural remodelling and mechanical consequences remain poorly defined. In this study we have developed a new collaborative bedside-to-bench workflow to determine the relationship between mammographic density, collagen abundance and alignment, tissue stiffness and the expression of extracellular matrix organising proteins. METHODS: Mammographic density was assessed in 22 post-menopausal women (aged 54-66 y). A radiologist and a pathologist identified and excised regions of elevated non-cancerous X-ray density prior to laboratory characterization. Collagen abundance was determined by both Masson's trichrome and Picrosirius red staining (which enhances collagen birefringence when viewed under polarised light). The structural specificity of these collagen visualisation methods was determined by comparing the relative birefringence and ultrastructure (visualised by atomic force microscopy) of unaligned collagen I fibrils in reconstituted gels with the highly aligned collagen fibrils in rat tail tendon. Localised collagen fibril organisation and stiffness was also evaluated in tissue sections by atomic force microscopy/spectroscopy and the abundance of key extracellular proteins was assessed using mass spectrometry. RESULTS: Mammographic density was positively correlated with the abundance of aligned periductal fibrils rather than with the abundance of amorphous collagen. Compared with matched tissue resected from the breasts of low mammographic density patients, the highly birefringent tissue in mammographically dense breasts was both significantly stiffer and characterised by large (>80 μm long) fibrillar collagen bundles. Subsequent proteomic analyses not only confirmed the absence of collagen fibrosis in high mammographic density tissue, but additionally identified the up-regulation of periostin and collagen XVI (regulators of collagen fibril structure and architecture) as potential mediators of localised mechanical stiffness. CONCLUSIONS: These preliminary data suggest that remodelling, and hence stiffening, of the existing stromal collagen microarchitecture promotes high mammographic density within the breast. In turn, this aberrant mechanical environment may trigger neoplasia-associated mechanotransduction pathways within the epithelial cell population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Fig. 6 Proteomic analysis of low and high mammographic density (MD) tissue. Proteins exhibiting >2-fold difference in abundance between tissue samples derived from patients with low and high MD. Red bars indicate greater abundance in tissue from patients with high MD: apolipoprotein D (APOD), a breast cyst fluid component and potentially a progesterone transporter [65], which is expressed in ductal carcinoma [66]; prolactin-inducible protein (PIP), a fibronectin-degrading aspartyl proteinase [67], which is frequently expressed in androgen receptor-positive breast tumours [68]; polymeric immunoglobulin receptor (PIGR), an epithelial cell-surface-located [69] biomarker of metastatic breast cancer [70]; zinc-alpha-2-glycoprotein (AZGP1), which stimulates lipolysis in adipocytes and is expressed in up 50 % of human breast cancers [71]; collagen XVI alpha 1 chain and periostin (COL16A1 and PSTN), extracellular matrix (ECM)-regulating proteins, which control collagen fibril interactions [50–52]; and two further proteins: immunoglobulin J (IGJ) and ACTN4, which have no known links to cancer or ECM remodelling [72, 73]. Proteins with a greater abundance in low MD tissue include: myeloperoxidase (MPO), serum markers of breast cancer including the neutrophil activity marker myeloperoxidase [74]; S100A8 and S100A9 (proinflammatory regulators [75, 76]), which play an as-yet poorly defined role in metastasis [77, 78]; C5 (a proteolytic degradation product of complement C5 [79], S100A11), which facilitates keratinocyte differentiation; apolipoprotein C-I (APOC1), an inhibitor of lipoprotein/LDL receptor binding [80], which may promote chronic low-grade inflammation and breast cancer [81]; inter-alpha-trypsin inhibitor heavy chain H1 (H1ITIH1), a hyaluronan binding protein [82], which is implicated in inflammation and downregulated in breast cancer [83]; HRG, histidine-rich glycoprotein, which inhibits tumour vascularisation [84, 85]; apolipoprotein A-I (APOA1), which is reported to be protective against breast cancer [86]; SERPINB6, an ECM protease inhibitor [54]; coagulation factor XIII A chain (F13A1), which inhibits degradation of collagen precursors [53]; glucose-6-phosphate isomerase (GPI), which modulates cancer cell phenotype [87]; apolipoprotein A-IV (APOA4) - blood plasma levels are significantly reduced in BRCA1 mutation carriers modulate [88]; laminin subunit beta-2 (LAMB2), a component of basement membranes, which is implicated in tumour angiogenesis [89]. Both serum paraoxonase/arylesterase 1 (PON1) and mitochondrial 60 kDa heat shock protein (HSPD1) appear to be unrelated to either matrix homeostasis or tumourigenesis](https://figures.cochat.ai/paper-figures/d18c46798b72464fa4d567f79ccc226e/increased-periductal-collagen-microorganization-may-contribute-to-raised-figure-6.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, breast cancer samples have a remarkably high fibrillar collagen content, leading to a poor prognosis [76, 77].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [77]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 107 · Cited by 110
Research works printed but not linked: 2
- Highnam R, Brady M, Yaffe MJ, Karssemeijer N, Harvey J. Robust breast composition measurement- Volpara(TM). In: Digital Mammography. Germany: Springer Berlin Heidelberg; 2010. p. 342-9.doi: 10.1186/s13058-015-0664-2
- Baldwin SJ, Quigley AS, Clegg C, Kreplak L. Nanomechanical mapping of hydrated Rat tail tendon collagen I fibrils. Biophys J. 2014;107(8):1794–801. · DOI
Metadata
- Authors
- McConnell, J. C., O’Connell, O. V., Brennan, K., Weiping, L., Howe, M., Joseph, L., Knight, D., O’Cualain, R., Lim, Y., Leek, A., Waddington, R., Rogan, J., Astley, S. M., Gandhi, A., Kirwan, C. C., Sherratt, M. J., & Streuli, C. H.
- Affiliations
- University of Manchester (GB)
- Wellcome Centre for Cell-Matrix Research (GB)
- Manchester Academic Health Science Centre (GB)
- Corresponding author
- McConnell, James C.
- O’Connell, Oliver V.
- Brennan, Keith
- Weiping, Lisa
- Howe, Miles
- Joseph, Leena
- Knight, David
- Lim, Yit
- Leek, Angela
- Waddington, Rachael
- Rogan, Jane
- Astley, Susan M.
- Gandhi, Ashu
- Kirwan, Cliona C.
- Sherratt, Michael J.
- Streuli, Charles H.
- ORCID
- Venue
- Breast Cancer Research
- Published
- 2016-01-08
- Volume
- 18
- Issue
- 1
- Pages
- 5-5
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- PMC
- PMC4706673
- OpenAlex
- W2231580835
- Cited by
- 110
- References
- 107
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 16 · 2020: 9 · 2019: 13 · 2018: 21 · 2017: 9 · 2016: 9
- FWCI
- 15.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Breast Cancer Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, cc-by)
- Funders
- Genesis Breast Cancer Prevention (R116883)
- Medical Research Council (G1001398)
- ISSF Biomedical Research Consortia
- Wellcome Trust (097820/Z/11/A)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Digital Radiography and Breast Imaging
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- breast density, breast cancer risk, collagen fibril alignment, tissue stiffness, extracellular matrix, periostin, fibroglandular tissue, mechanotransduction, collagen birefringence
- MeSH terms
- Breast Density, Aged, Animals, Breast Neoplasms, Collagen, Female, Humans, Mammography, Middle Aged, Risk Factors, Cell Adhesion Molecules, Extracellular Matrix Proteins, Microscopy, Atomic Force, Proteomics, Mammary Glands, Human, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased peri‐ductal collagen micro‐organization may contribute to raised mammographic density. https://app.cochat.ai/papers/10.1186/s13058-015-0664-2
- The paper
- McConnell, J. C., O’Connell, O. V., Brennan, K., Weiping, L., Howe, M., Joseph, L., Knight, D., O’Cualain, R., Lim, Y., Leek, A., Waddington, R., Rogan, J., Astley, S. M., Gandhi, A., Kirwan, C. C., Sherratt, M. J., & Streuli, C. H. (2016). Increased peri‐ductal collagen micro‐organization may contribute to raised mammographic density. Breast Cancer Research. https://doi.org/10.1186/s13058-015-0664-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.